Harbeck N - Search Results

1

The patched polymorphism Pro1315Leu (C3944T) may modulate the association between use of oral contraceptives and breast cancer risk.

Chang-Claude J, Dunning A, Schnitzbauer U, Galmbacher P, Tee L, Wjst M, Chalmers J, Zemzoum I, Harbeck N, Pharoah PD, Hahn H. Chang-Claude J, et al. Among authors: harbeck n. Int J Cancer. 2003 Mar 1;103(6):779-83. doi: 10.1002/ijc.10889. Int J Cancer. 2003. PMID: 12516098 Free article.

2

Clinical utility of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 determination in primary breast cancer tissue for individualized therapy concepts.

Harbeck N, Schmitt M, Kates RE, Kiechle M, Zemzoum I, Jänicke F, Thomssen C. Harbeck N, et al. Clin Breast Cancer. 2002 Aug;3(3):196-200. doi: 10.3816/CBC.2002.n.023. Clin Breast Cancer. 2002. PMID: 12196277 Review.

3

Invasion factors uPA/PAI-1 and HER2 status provide independent and complementary information on patient outcome in node-negative breast cancer.

Zemzoum I, Kates RE, Ross JS, Dettmar P, Dutta M, Henrichs C, Yurdseven S, Höfler H, Kiechle M, Schmitt M, Harbeck N. Zemzoum I, et al. Among authors: harbeck n. J Clin Oncol. 2003 Mar 15;21(6):1022-8. doi: 10.1200/JCO.2003.04.170. J Clin Oncol. 2003. PMID: 12637466

4

Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancer.

Christgen M, Gluz O, Harbeck N, Kates RE, Raap M, Christgen H, Clemens M, Malter W, Nuding B, Aktas B, Kuemmel S, Reimer T, Stefek A, Krabisch P, Just M, Augustin D, Graeser M, Baehner F, Wuerstlein R, Nitz U, Kreipe H; West German Study Group PlanB Investigators. Christgen M, et al. Among authors: harbeck n. Cancer. 2020 Nov 15;126(22):4847-4858. doi: 10.1002/cncr.33104. Epub 2020 Aug 11. Cancer. 2020. PMID: 32780421 Free article.

5

Recent advances in technologies for the detection of occult metastatic cells in bone marrow of breast cancer patients.

Braun S, Harbeck N. Braun S, et al. Among authors: harbeck n. Breast Cancer Res. 2001;3(5):285-8. doi: 10.1186/bcr308. Epub 2001 Jun 28. Breast Cancer Res. 2001. PMID: 11597315 Free PMC article. Review.

6

Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1.

Janz M, Harbeck N, Dettmar P, Berger U, Schmidt A, Jürchott K, Schmitt M, Royer HD. Janz M, et al. Among authors: harbeck n. Int J Cancer. 2002 Jan 20;97(3):278-82. doi: 10.1002/ijc.1610. Int J Cancer. 2002. PMID: 11774277 Free article.

7

Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele.

Bange J, Prechtl D, Cheburkin Y, Specht K, Harbeck N, Schmitt M, Knyazeva T, Müller S, Gärtner S, Sures I, Wang H, Imyanitov E, Häring HU, Knayzev P, Iacobelli S, Höfler H, Ullrich A. Bange J, et al. Among authors: harbeck n. Cancer Res. 2002 Feb 1;62(3):840-7. Cancer Res. 2002. PMID: 11830541

8

C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu.

Lengyel E, Prechtel D, Resau JH, Gauger K, Welk A, Lindemann K, Salanti G, Richter T, Knudsen B, Vande Woude GF, Harbeck N. Lengyel E, et al. Among authors: harbeck n. Int J Cancer. 2005 Feb 10;113(4):678-82. doi: 10.1002/ijc.20598. Int J Cancer. 2005. PMID: 15455388 Free article.

9

Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker.

Sadr-Nabavi A, Ramser J, Volkmann J, Naehrig J, Wiesmann F, Betz B, Hellebrand H, Engert S, Seitz S, Kreutzfeld R, Sasaki T, Arnold N, Schmutzler R, Kiechle M, Niederacher D, Harbeck N, Dahl E, Meindl A. Sadr-Nabavi A, et al. Among authors: harbeck n. Int J Cancer. 2009 Apr 1;124(7):1727-35. doi: 10.1002/ijc.24108. Int J Cancer. 2009. PMID: 19115204 Free article.

10

Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials.

von Minckwitz G, Untch M, Nüesch E, Loibl S, Kaufmann M, Kümmel S, Fasching PA, Eiermann W, Blohmer JU, Costa SD, Mehta K, Hilfrich J, Jackisch C, Gerber B, du Bois A, Huober J, Hanusch C, Konecny G, Fett W, Stickeler E, Harbeck N, Müller V, Jüni P. von Minckwitz G, et al. Among authors: harbeck n. Breast Cancer Res Treat. 2011 Jan;125(1):145-56. doi: 10.1007/s10549-010-1228-x. Epub 2010 Nov 3. Breast Cancer Res Treat. 2011. PMID: 21042932 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

689 results

Search Page